MAP2K7 and cancer: It has previously been shown that TNKS inhibition sensitizes KRAS mutant cancer cells to growth inhibition by MEK inhibitors [13], also in cell lines whose proliferation rate is unaffected by single TNKS inhibitor treatment [14].